HSHygor Marcos Ribeiro de Souza

Hygor Marcos Ribeiro de Souza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hygor Marcos Ribeiro de Souza has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Metabolite profiling of pumpkin flowers from agronomically important varieties from the Agreste region of Pernambuco (Brazil) using a multi-platform metabolomic approach

    by Hygor M. R. Souza, Gabriela R. A. Soliz, Aline Gabrielle Alves de Carvalho, Maria Fernanda C. Guimarães, Desirée L. Reis, Mariana P. P. S. da Cruz, Thamizy M. S. Macedo, Tatiana El-Bacha, Emmanuela Paiva Azevedo, Alexandre Guedes Torres

    Pumpkin flowers (Cucurbita spp.) are traditionally consumed edible tissues with recognized nutritional, although their chemical composition remains insufficiently characterized. In this study, the metabolic profiles of male flowers from four pumpkin varieties cultivated in northeastern Brazil were investigated using an integrated metabolomics approach based on LC–HRMS, GC–MS, and 1H NMR. A total of 156 metabolites were annotated across multiple chemical classes, including amino acids, sugars, phenylpropanoids, flavonoids, terpenoids, and fatty acids. Multivariate and univariate analyses revealed clear metabolic differences among varieties, particularly in carbohydrate, amino acid, and phenolic profiles, indicating strong genotype-dependent variability. In contrast, no significant differences were observed between flowers collected from across the planting beds. The multi-platform approach provided broad chemical coverage and improved annotation confidence. These results expand current knowledge of Cucurbita floral metabolism and support the nutritional and technological valorization of pumpkin flowers as an underexplored food resource.

  • Untargeted Metabolomics of Dried Urine Spot Samples from Pompe Disease Patients

    by Hygor M. R. de Souza, Clarisse L. Torres, Fernanda B. Scalco, Flávia F. de C. Marques, Rafael Garrett

    Dried blood samples on filter paper have been used in newborn screening programs for decades and have recently gained attention as a practical alternative to traditional liquid matrices for untargeted metabolomics. This material provides benefits, such as long-term stability and cost-effective transportation, which are particularly valuable for rare disease studies. While dried blood spots are well-established in clinical and research settings, dried urine spots (DUS) remain largely unexplored for untargeted metabolomics, despite their potential as a noninvasive matrix for biomarker discovery. In this study, it was conducted an exploratory untargeted metabolomics investigation using liquid chromatography-high-resolution mass spectrometry (LC-HRMS) to analyze DUS samples from individuals with Pompe disease (PD). Using an integrated data analysis strategy that combined univariate testing with multivariate and machine learning methods, 29 metabolites that differed significantly (p < 0.05) between Pompe disease patients and controls were annotated. Of these, six have been previously reported in liquid urine, confirming that DUS is a reliable sampling method for biomarker detection and discovery. In conclusion, our results demonstrate that untargeted LC-HRMS analysis of DUS offers a reliable alternative for urine studies, highlighting specific metabolic changes in Pompe disease and supporting its application in research on rare disorders.

  • Gas and Liquid Chromatography–Mass Spectrometry Investigation of Viscum Album Lipophilic Extracts

    by Hygor M. R. de Souza, Aline G. A. de Carvalho, Michelle Nonato de Oliveira Melo, Jakob Maier, Carla Holandino, Stephan Baumgartner, Rafael Garrett


  • Biomarkers of fried food intake: a systematic review of in vivo studies

    by Aline G. A. Carvalho, Luana O. Oliveira, Hygor M. R. de Souza, Gabriela R. A. Soliz, Maria Fernanda C. Guimarães, Fabio A. Oroski, Vanessa N. Castelo-Branco, Tatiana El-Bacha, Alexandre G. Torres

    In vivo studies disclose biomarkers of fried food intake, via MS-based metabolomics.

  • Open Access

    Design, Synthesis, and Evaluation of Antinociceptive Properties of Novel CBD-Based Terpene-Cinnamoyl-Acyl-Hydrazone Analogues

    by Mikaela Lucinda de Souza, João Pedro Barros de Paiva, Graziella dos Reis Rosa Franco, Vanessa Silva Gontijo, Marina Amaral Alves, Hygor Marcos Ribeiro de Souza, Anna Carolina Pereira Lontra, Eduardo Araújo de Oliveira, Thaís Biondino Sardella Giorno, Isabella Alvim Guedes, et al.

    Background/Objectives: Cannabidiol (CBD) has been reported for its antinociceptive, anti-inflammatory, and neuroprotective activities. However, several legal restrictions on its medicinal uses and even research have contributed to the development of synthetic analogues. Therefore, the aim of this study was the design and synthesis of a novel series of CBD-based structural analogues, and the in vivo evaluation of their potential antinociceptive activity. Methods: Using a two-step synthetic route, 26 new terpene-cinnamoyl acyl-hydrazone analogues were obtained and were submitted to in vivo screening in the classical formalin-induced paw edema and hot plate assays. Results: The compounds PQM-292, PQM-293, PQM-295, PQM-307, PQM-308, and PQM-309 exhibited the best results in the neurogenic phase (first phase) of the formalin-induced licking response, showing comparable results to morphine. Notably, in the inflammatory phase (second phase), compound PQM-292 exhibited the best anti-inflammatory activity. Interestingly, in the hot plate model, six other compounds (PQM-274, PQM-291, PQM-294, PQM-304, PQM-305, and PQM-378) showed the best antinociceptive activity in comparison to morphine, especially PQM-274, which exhibited an antinociceptive effect almost equivalent to the reference drug. Interestingly, these findings suggested that these bioactive compounds, despite their structural similarity, act through different mechanisms, which were investigated by molecular docking with CB1, CB2, and TRPV1 receptors. In silico results indicated that the most active compounds should act through different mechanisms, probably involving interactions with TRPA1. Conclusions: Therefore, due to the promising antinociceptive activity observed for these highlighted compounds, particularly for PQM-292 and PQM-274, without apparent toxicity and psychoactive effects, and the possible involvement of diverse mechanisms of action, these compounds could be considered as promising starting points to the development of new drug candidate prototypes of clinical interest.


  • Open Access

    Design, Synthesis, and Evaluation of Antinociceptive Properties of Novel CBD-Based Terpene-Cinnamoyl-Acyl-Hydrazone Analogues

    by Mikaela Lucinda de Souza, João Pedro Barros de Paiva, Graziella dos Reis Rosa Franco, Vanessa Silva Gontijo¹, Marina Amaral Alves², Hygor Marcos Ribeiro de Souza, Anna Carolina Pereira Lontra, Eduardo Araújo de Oliveira, Thaís Biondino Sardella Giorno, Isabella Alvim Guedes, et al.

    Background/Objectives: Cannabidiol (CBD) has been reported for its antinociceptive, anti-inflammatory, and neuroprotective activities. However, several legal restrictions for its medicinal uses, and even research, have contributed to the development of synthetic analogues. Therefore, the aim of this study was the design and synthesis of a novel series of CBD-based structural analogues, and the in vivo evaluation of their potential antinociceptive activity. Methods: Using a two-step synthetic route, 26 new terpene-cinnamoyl acyl-hydrazone analogues were obtained and were submitted in vivo screening in the classical formalin-induced paw edema and hot plate assays. Results: Compounds PQM-292, PQM-293, PQM-295, PQM-307, PQM-308, and PQM-309 exhibited the best results in the neurogenic phase (1st Phase) of the formalin-induced licking response, showing comparable results to morphine. Notably, in the inflammatory phase (2nd Phase), compound PQM-292 exhibited the best anti-inflammatory activity. Interestingly, in the hot plate model, other six compounds (PQM-274, PQM-291, PQM-294, PQM-304, PQM-305, and PQM-378) showed the best antinociceptive activity in comparison to morphine, especially PQM-274 which exhibited an antinociceptive effect almost equivalent to the reference drug. Interestingly, these findings suggested that these bioactive compounds, despite their structural similarity, act through different mechanisms, which were investigated by molecular docking with CB1, CB2, and TRPV1 receptors. In silico results indicated that the most active compounds should act through different mechanisms, probably involving interactions with TRPA1. Conclusions: Therefore, due to the promising antinociceptive activity observed for these highlighted compounds, particularly for PQM-292 and PQM-274, without apparent toxicity and psychoactive effects, and the possible involvement of diverse mechanisms of action, these compounds could be considered as promising starting points to the development of new drug candidate prototypes of clinical interest.


  • Open Access

    Critical Factors in Sample Collection and Preparation for Clinical Metabolomics of Underexplored Biological Specimens

    by Hygor M. R. de Souza, Tássia T. P. Pereira, Hanna C. de Sá, Marina A. Alves, Rafael Garrett, Gisele A. B. Canuto

    This review article compiles critical pre-analytical factors for sample collection and extraction of eight uncommon or underexplored biological specimens (human breast milk, ocular fluids, sebum, seminal plasma, sweat, hair, saliva, and cerebrospinal fluid) under the perspective of clinical metabolomics. These samples are interesting for metabolomics studies as they reflect the status of living organisms and can be applied for diagnostic purposes and biomarker discovery. Pre-collection and collection procedures are critical, requiring protocols to be standardized to avoid contamination and bias. Such procedures must consider cleaning the collection area, sample stimulation, diet, and food and drug intake, among other factors that impact the lack of homogeneity of the sample group. Precipitation of proteins and removal of salts and cell debris are the most used sample preparation procedures. This review intends to provide a global view of the practical aspects that most impact results, serving as a starting point for the designing of metabolomic experiments.


  • Open Access

    Integrated NMR and MS Analysis of the Plasma Metabolome Reveals Major Changes in One-Carbon, Lipid, and Amino Acid Metabolism in Severe and Fatal Cases of COVID-19

    by Marcos C. Gama-Almeida, Gabriela D. A. Pinto, Lívia Teixeira, Eugenio D. Hottz, Paula Ivens, Hygor Ribeiro, Rafael Garrett, Alexandre G. Torres, Talita I. A. Carneiro, Bianca de O. Barbalho, et al.

    Brazil has the second-highest COVID-19 death rate worldwide, and Rio de Janeiro is among the states with the highest rate in the country. Although vaccine coverage has been achieved, it is anticipated that COVID-19 will transition into an endemic disease. It is concerning that the molecular mechanisms underlying clinical evolution from mild to severe disease, as well as the mechanisms leading to long COVID-19, are not yet fully understood. NMR and MS-based metabolomics were used to identify metabolites associated with COVID-19 pathophysiology and disease outcome. Severe COVID-19 cases (n = 35) were enrolled in two reference centers in Rio de Janeiro within 72 h of ICU admission, alongside 12 non-infected control subjects. COVID-19 patients were grouped into survivors (n = 18) and non-survivors (n = 17). Choline-related metabolites, serine, glycine, and betaine, were reduced in severe COVID-19, indicating dysregulation in methyl donors. Non-survivors had higher levels of creatine/creatinine, 4-hydroxyproline, gluconic acid, and N-acetylserine, indicating liver and kidney dysfunction. Several changes were greater in women; thus, patients’ sex should be considered in pandemic surveillance to achieve better disease stratification and improve outcomes. These metabolic alterations may be useful to monitor organ (dys) function and to understand the pathophysiology of acute and possibly post-acute COVID-19 syndromes.


  • Development of a kit for urine collection on filter paper as an alternative for Pompe disease screening and monitoring by LC-HRMS

    by Hygor M. R. de Souza, Fernanda B. Scalco, Rafael Garrett, Flávia F. de C. Marques

    This work reports the validation and application of a method for determination of glucose tetrasaccharide (Glc 4 ) in urine collected on filter paper for monitoring Pompe disease patients.


  • Open Access

    Integrated NMR and MS analysis of plasma metabolome reveals major changes in inflammatory markers, one-carbon, lipid, and amino acid metabolism in severe and fatal COVID-19 subjects

    by Marcos C. Gama-Almeida, Lívia Teixeira, Eugenio D. Hottz, Paula Ivens, Hygor Ribeiro, Gabriela D. A. Pinto, Rafael Garrett, Alexandre G. Torres, Talita I. A. Carneiro, Bianca de O Barbalho, et al.

    Brazil has the second highest COVID-19 death rate while Rio de Janeiro is among the states with the highest rate in the country. Although effective vaccines have been developed, it is anticipated that the ongoing COVID-19 pandemic will transition into an endemic state. Under this scenario, it is worrisome that the underlying molecular mechanisms associated with the disease clinical evolution from mild to severe, as well as the mechanisms leading to long COVID are not yet fully understood. In this study, 1 H Nuclear Magnetic Resonance spectroscopy and Liquid Chromatography-Mass spectrometry-based metabolomics were used to identify potential pathways and metabolites involved in COVID-19 pathophysiology and disease outcome. We prospectively enrolled 35 severe RT-PCR confirmed COVID-19 cases within 72 hours from intensive care unit admission, between April and July 2020 from two reference centers in Rio de Janeiro, and 12 samples from non-infected control subjects. Of the 35 samples from COVID-19 patients, 18 were from survivors and 17 from non-survivors. We observed that patients with severe COVID-19 had their plasma metabolome significantly changed if compared to control subjects. We observed lower levels of glycerophosphocholine and other choline-related metabolites, serine, glycine, and betaine, indicating a dysregulation in methyl donors and one-carbon metabolism. Importantly, non-survivors had higher levels of creatine/creatinine, 4-hydroxyproline, gluconic acid and N -acetylserine compared to survivors and controls, reflecting uncontrolled inflammation, liver and kidney dysfunction, and insulin resistance in these patients. Lipoprotein dynamics and amino acid metabolism were also altered in severe COVID-19 subjects. Several changes were greater in women, thus patient’s sex should be considered in pandemic surveillance to achieve better disease stratification and improve outcomes. The incidence of severe outcome after hospital discharge is very high in Brazil, thus these metabolic alterations may be used to monitor patients’ organs and tissues and to understand the pathophysiology of long-post COVID-19.